AzTrials
AzTrials

Acute DiseaseECHO-CTNCT03832257

Improving Safety of Transitions to Skilled Nursing Care Using Videoconferencing

A study testing ECHO CT Intervention and Matched Non-Participating Facilities in people with Acute Disease, run by Beth Israel Deaconess Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective cohort study seeks to determine if the ECHO-CT program, a healthcare videoconferencing program, can improve clinical outcomes while reducing cost and resource utilization when expanded to a community hospital setting. Data will be analyzed on the facility level and patient level. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Acute Disease
What is being tested?
ECHO CT Intervention and Matched Non-Participating Facilities
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10,708 participants
Where
1 siteUnited States
Study dates
30 Sep 2018to 31 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Facility Inclusion Criteria:

  • SNF receives approximately the middle third of referral volume (approx. 20-100 referrals/ average 40 per year)
  • SNF not so highly engaged with acute hospital that their patients are less likely to benefit from the intervention.
  • SNF affiliated with BIDMC Boston or BIDMC Needham

Facility Exclusion Criteria:

  • Has not recently participated in ECHO CT
  • Do not send anyone to ECHO CT training
  • Clinicians are unwilling to make a commitment to attend at least 75% of video conferences

Patient Selection:

ECHO-CT Group:

Inclusion Criteria: Patients that were discharged from BIDMC and admitted to skilled nursing facilities that are participating in ECHO-CT between April 2019 and March 2021.

Exclusion Criteria: Patients discharged from a hospital other than BIDMC. Patients admitted to a skilled nursing facility that is not participating in ECHO-CT.

Control Group:

Inclusion Criteria: Patients from skilled nursing facilities not participating in ECHO.

Exclusion Criteria: Patients discharged from BIDMC to one of our participating SNFs during the study period of April 2019- March 2021

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215

Other trials in United States

About this study

Official title: AHRQ Health Services Research Projects: Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities

This prospective cohort study seeks to determine if the ECHO-CT program, a healthcare videoconferencing program, can improve clinical outcomes while reducing cost and resource utilization when expanded to a community hospital setting. Data will be analyzed on the facility level and patient level.

Read the detailed description

ECHO-Care Transitions is a healthcare outreach program utilizing videoconferencing technology to improve the quality and efficiency of care transitions for medically-complex elderly patients by connecting post-acute care facilities that receive BIDMC patients with a multidisciplinary BIDMC team that sends these patients following discharge. This case-control study seeks to determine if ECHO-CT can improve clinical outcomes and reduce cost and resource utilization during transitions of care in both an academic (BIDMC Boston) and community (BIDMC Needham) hospital.

Our prospective cohort study of the ECHO-CT intervention will take place in the two Boston-area hospitals, one providing tertiary care and one community-based care, in which the outcomes of patients transferred to Skilled Nursing Facilities (SNFs) associated with these hospitals will be compared to those transferred to SNFs from similar hospitals in New England. We will also be comparing outcomes from individual patients enrolled in the ECHO program to matched controls. Using a national database available from the Brown University Center for Gerontology and Healthcare Research, the outcomes of Medicare beneficiaries residing in SNFs that are participating in ECHO-CT will be compared to those in the comparison group using a difference-of-difference analytic approach. Analyses will be adjusted for potential confounders as appropriate.

In this study, the investigators also plan to measure satisfaction as well as process, utilization, cost and patient safety outcomes to determine best practices for implementing the program at a community hospital and affiliated SNFs.

Data will be obtained from the following sources:

  1. Protected health information (PHI) from resident assessment data, as well as Medicare claims and enrollment data to be obtained via a data use agreement (DUA) with the Centers for Medicare and Medicaid Services (CMS) by the Brown University Center for Gerontology and Health Care Research during years 2-3 of the study to include the following:
  2. The resident Minimum Data Set Resident Assessment (MDS) assessments. The MDS has nearly 400 data elements including cognitive function, communication/hearing problems, physical functioning, continence, psycho-social well-being, mood state, activity and recreation, diagnoses, health conditions, nutritional status, oral/dental status, skin conditions, special treatments, and medication use. The assessments are done for all patients admitted to Medicare and Medicaid certified SNFs, including enrollees in both traditional Medicare and Medicare Advantage. These data will already be housed at Brown University,Brown has an active DUA to obtain quarterly pulls of the population of MDS assessments .
  3. Medicare claims which will be used to ascertain 30-day costs, re-hospitalizations, and use of other medical services by Medicare fee for service (FFS) patients admitted to the SNFs. The data also include diagnosis fields to ascertain comorbidities.
  4. Medicare enrollment file includes demographic information such as sex and race, dates of birth and death, and various indicators of Medicare/Medicaid eligibility, Part D eligibility, and Medicare Advantage enrollment.
  5. BIDMC will collect and share ECHO-CT participating patient's social security number and health insurance claims number with Brown University. Their clinical information will be matched with control patients from the Medicare claims data to show study effect on 30-day costs, re-hospitalizations rate and patient length of stay.
  6. In addition to aggregates derived from above, facility level data will come from the Certification and Survey Provider Enhanced Reporting (CASPER) data, which are publicly available and based upon facility surveys for Medicare/Medicaid certification. They will be used in addition to data from "Nursing Home Compare and the Long Term Care: Facts on Care in the US (LTCFocus.org) websites to describe the SNFs.
  7. Intervention-specific data: Project-specific quality improvement data derived from questionnaires, staff satisfaction surveys, and structured meeting minutes will be designed and evaluated by BIDMC and Hebrew Senior Life
  8. SNF Satisfaction: Every 6 months the investigators will send a satisfaction questionnaire to the hospitals and SNFs participating in ECHO-CT to assess their views of the ECHO-CT sessions, the value of time spent, feelings of empowerment, inter-professional relationships, learning, and recommendations. All answers to the survey questions will be kept strictly confidential. This information will be used to improve the content and organization of the sessions and to develop tools for dissemination (Aim 3). The investigators will develop the satisfaction questionnaire during the first 6 months of the project, building upon our previous survey experience and literature review. Metrics to quantify the quality of transitional care will be derived from the work of Coleman et al.3 and incorporated into the questionnaire. Survey design and evaluation will be conducted by the outcome evaluation group under the leadership of Dr. Thomas Travison at Hebrew SeniorLife's Institute for Aging Research.
  9. Process assessment: The investigators will keep attendance logs to assess adherence to the ECHO-CT intervention and its changes over time. Any consistent decline in staff attendance for 2 or more weeks will be followed up by phone calls to assess barriers to participation and corrective actions will be taken. These may include changing to a more convenient time, identifying other providers who can attend instead, contacting facility administrators or medical directors for their support, and providing incentive gifts or continuing education credits In addition, during each ECHO-CT session, the hospital based team will inquire about unexpected outcomes or issues that arose during the transition process, including those related to patients already discussed. This element will allow for an ongoing technology-enabled learning platform and continuous quality improvement mechanism over the course of the proposed project. The value of the video-conferencing approach is that it creates a mutually trusting learning community in which "all teach and all learn."
Conditions
Acute Disease
Being tested
ECHO CT Intervention, Matched Non-Participating Facilities
Medical subject headings
Acute Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ECHO CT InterventionOther

    weekly video conference between hospitalist and skilled nursing facilities

  • Matched Non-Participating FacilitiesOther

    Matched Non-Participating Facilities

Study groups in NCT03832257
Study groupRoleWhat they receive
ECHO CT InterventionExperimentalWeekly video conference between hospitalist at Beth Israel and skilled nursing facilities.
Receives: Other: ECHO CT Intervention
Matched Non- Participating FacilitiesOtherMatched non-participating facilities
Receives: Other: Matched Non-Participating Facilities

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 30-Day Readmission Rates

    Number of hospital readmissions over 30 day period among participating SNF sites

    Measured: 30-Days

Secondary outcomes (2)
  1. Health Care Utilization

    Includes average length of stay in the facility

    Measured: up to 90 days

  2. Health Care Cost

    Total 30-day Medicare costs for fee-for-service patients.

    Measured: 30-days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2019
  2. Study start30 Sep 2018
  3. Primary completion31 Aug 2023
  4. Study completion31 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
10,708 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03832257
Sponsor's protocol ID
2018P000457
Acronym
ECHO-CT
Status last verified
Nov 2023
First submitted
3 Feb 2019
Last updated
30 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Arora S, Thornton K, Jenkusky SM, Parish B, Scaletti JV. Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico. Public Health Rep. 2007;122 Suppl 2(Suppl 2):74-7. doi: 10.1177/00333549071220S214.

    PubMed 17542458
  • Arora S, Thornton K, Murata G, Deming P, Kalishman S, Dion D, Parish B, Burke T, Pak W, Dunkelberg J, Kistin M, Brown J, Jenkusky S, Komaromy M, Qualls C. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med. 2011 Jun 9;364(23):2199-207. doi: 10.1056/NEJMoa1009370. Epub 2011 Jun 1.

    PubMed 21631316
  • Boltz M, Parke B, Shuluk J, Capezuti E, Galvin JE. Care of the older adult in the emergency department: nurses views of the pressing issues. Gerontologist. 2013 Jun;53(3):441-53. doi: 10.1093/geront/gnt004. Epub 2013 Feb 26.

    PubMed 23442380
  • Coleman EA, Berenson RA. Lost in transition: challenges and opportunities for improving the quality of transitional care. Ann Intern Med. 2004 Oct 5;141(7):533-6. doi: 10.7326/0003-4819-141-7-200410050-00009.

    PubMed 15466770
  • Kessler C, Williams MC, Moustoukas JN, Pappas C. Transitions of care for the geriatric patient in the emergency department. Clin Geriatr Med. 2013 Feb;29(1):49-69. doi: 10.1016/j.cger.2012.10.005.

    PubMed 23177600
  • Moore AB, Krupp JE, Dufour AB, Sircar M, Travison TG, Abrams A, Farris G, Mattison MLP, Lipsitz LA. Improving Transitions to Postacute Care for Elderly Patients Using a Novel Video-Conferencing Program: ECHO-Care Transitions. Am J Med. 2017 Oct;130(10):1199-1204. doi: 10.1016/j.amjmed.2017.04.041. Epub 2017 May 25.

    PubMed 28551043
  • Marks C, Loehrer S, McCarthy D. Hospital readmissions: measuring for improvement, accountability, and patients. Issue Brief (Commonw Fund). 2013 Sep;24:1-8.

    PubMed 24044140
  • Mor V, Intrator O, Feng Z, Grabowski DC. The revolving door of rehospitalization from skilled nursing facilities. Health Aff (Millwood). 2010 Jan-Feb;29(1):57-64. doi: 10.1377/hlthaff.2009.0629.

    PubMed 20048361
  • LaMantia MA, Scheunemann LP, Viera AJ, Busby-Whitehead J, Hanson LC. Interventions to improve transitional care between nursing homes and hospitals: a systematic review. J Am Geriatr Soc. 2010 Apr;58(4):777-82. doi: 10.1111/j.1532-5415.2010.02776.x.

    PubMed 20398162
  • Austin BJ. Rehospitalization from skilled nursing facilities: implications for policy. Find Brief. 2010 Feb;12(9):1-3.

    PubMed 20222212
  • Ouslander JG, Diaz S, Hain D, Tappen R. Frequency and diagnoses associated with 7- and 30-day readmission of skilled nursing facility patients to a nonteaching community hospital. J Am Med Dir Assoc. 2011 Mar;12(3):195-203. doi: 10.1016/j.jamda.2010.02.015. Epub 2010 Aug 12.

    PubMed 21333921

Questions about this trial

What is this clinical trial studying?

A study testing ECHO CT Intervention and Matched Non-Participating Facilities in people with Acute Disease, run by Beth Israel Deaconess Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

30-Day Readmission Rates (time frame: 30-Days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03832257, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in